ANTIBODY MEDIATED REJECTION
Clinical trials for ANTIBODY MEDIATED REJECTION explained in plain language.
Never miss a new study
Get alerted when new ANTIBODY MEDIATED REJECTION trials appear
Sign up with your email to follow new studies for ANTIBODY MEDIATED REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new infusion stop the Body's attack on a transplanted kidney?
Disease control Not yet recruitingThis trial tests an experimental drug called SG301 in people who have antibody-mediated rejection after a kidney transplant. The goal is to see if the drug is safe and may help control the immune system's attack on the new kidney. Participants receive the drug by infusion weekly …
Matched conditions: ANTIBODY MEDIATED REJECTION
Phase: PHASE2 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New Two-Step therapy aims to stop chronic kidney transplant rejection
Disease control Not yet recruitingThis study tests a new treatment for chronic active antibody-mediated rejection (caABMR) in kidney transplant recipients. Patients receive a single injection of a CD38 monoclonal antibody to deplete harmful immune cells, followed by long-term azathioprine pills to maintain contro…
Matched conditions: ANTIBODY MEDIATED REJECTION
Phase: NA • Sponsor: wujianyong • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC